Proteimax

📍 Rehovoth, Israel🗓 Founded 2020👥 3 employees💰 Last funded Jan 2022
Biotechnology Research
LinkedIn
Proteimax discovers and commercializes biologically active peptides. Its mission is to solve some of the most pressing problems of humanity, ranging from chronic disease to food loss. Proteimax was born in its discovery of a new class of peptides. Among them is a decapeptide produced in fat cells that flattens glycemic spikes, reduces fasting insulin, and promotes loss of body fat. This peptide is envisioned as a functional ingredient for a completely new, food based approach to the global epidemic of obesity and diabetes. The Proteimax peptide bank contains 54 members representing vast commercial potential. The company is seizing this potential sequentially, starting with the anti-obesity food additive. The company operates out of Rehovoth, Israel and Miami, Florida.
1
Total investors
1
Early stage
0
Mid stage
0
Late stage
2020
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
Israel
1
Frequently asked questions
Who invested in Proteimax?
Proteimax has 1 investors on record on gritt.io, including 1 early-stage backers.
When did Proteimax last raise funding?
The most recent investment in Proteimax recorded on gritt.io was in January 2022.
When was Proteimax founded?
Proteimax was founded in 2020.
What industry is Proteimax in?
Proteimax operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Proteimax based?
Proteimax is headquartered in Rehovoth, Israel.